Jason M. Vaughn,Justin R. Hughey,Tanesha Roberts,Tatyana Dyakonov,Sunil Agnihotri,Aqeel A. Fatmi
申请号：
US15730825
公开号：
US20180055804A1
申请日:
2017.10.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.
